Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
F. Martignano, S. Crucitta, A. Mingrino, R. Semeraro, M. Del Re, I. Petrini, A. Magi, S. G. Conticello
This study uses Nanopore sequencing on cell-free DNA from lung cancer patients to analyze copy number variations, showing it is a viable alternative to Illumina sequencing for rapid and cost-effective tumor DNA profiling.
Molecular Cancer · Dec 1, 2021Peer-reviewedCancer Biology